An invitation-only Meet the Investigator session entitled: Ongoing research and future opportunities in metastatic breast cancer, which is being held on Monday 30 September 2019 during the ESMO Annual Congress in Barcelona, Spain.

The aim of this session is to provide an opportunity for investigators in Seattle Genetics clinical development programme to meet and share insights, experience and ideas regarding the clinical evaluation of Seattle Genetics’ novel breast cancer therapies.

As an investigator invited to participate in this event, we would be grateful if you could complete all fields indicated.

SeaGen International GmbH (“SeaGen”), with registered office in Dammstrasse 19, Zug, Switzerland, will process the personal data you will share with us in this registration phase for the purpose of managing the event, including checking that you are an investigator of relevant SeaGen’s trials, to create internal statistics and for the mandatory reporting, if any. Your data may have to be transferred to service providers, all of whom are based in the EEA, that will support us in the organization of the event. Your data will be retained for compliance purposes not longer than necessary. By registering, you consent to the processing of your data in compliance with Article 6(a) of the General Data Protection Regulation (Regulation EU 2016/679, “GDPR”). For any questions regarding the processing of your data, as well as to exercise your rights according to GDPR Article 13.2, please write an email to EuropeDataProtection@seagen.com. SeaGen would like to remind you that you can lodge a complaint with the any Data Protection Authority, should you  have legitimate reasons to complain about the processing of your data.